Advertisement

#Covid19

NEJM Editors Blast Trump Administration’s Covid-19 Response

Oct 09, 2020

Storied journal stops short of endorsing a candidate For the first time in its more than 200-year history, the New England Journal of Medicine is weighing in on a U.S. election, calling the Trump adm...

Covid-19: Remdesivir Shortens Recovery Time in ACTT-1 Study

Oct 09, 2020

Hydroxychloroquine shows no benefit in RECOVERY trial A 10-day course of the antiviral drug remdesivir was superior to placebo for shortening the time to recovery in adults hospitalized with Covid-19...

Loneliness in the Children during the times of Covid 19

Oct 09, 2020

The children these days are already suffering a life of so much pain and anguish. People these days are so much alone and busy in their lives that they do not bother about the mental health of the chi...

The Prevalence of COVID-19 and its effects on Radiotherapy in India

Oct 08, 2020

The outbreak of the novel coronavirus has not only taken a toll on the life of the health people but also has made the lives of the people who have diagnosed with cancer more pathetic. This is because...

The Effectiveness of Anti-Cancer Therapy in Curing Breast Cancer during COVID-19

Oct 08, 2020

The sudden outbreak of the novel coronavirus has posed various challenges to the efficiency and adequacy of the healthcare systems worldwide. This is because of the reason that there is no treatment a...

The Impact of Acute Phase of COVID-19 on Radiotherapy

Oct 08, 2020

The sudden outbreak of the deadly virus known as coronavirus has worsened the condition fo the world for worse.  This is because of the reason that the people are not left with any option with them. ...

AMA Updates CPT Codes for Covid-19 Care

Oct 08, 2020

New codes account for multi-virus tests for Covid, flu CHICAGO — The American Medical Association announced the addition of two new Current Procedural Terminology (CPT) codes for tests that simulta...

Review: Estimated Prevalence of VTE 14.1 Percent in COVID-19

Oct 08, 2020

WEDNESDAY, Oct. 7, 2020 (HealthDay News) -- The overall prevalence of venous thromboembolism (VTE) in patients with COVID-19 is estimated to be 14.1 percent, with a higher prevalence for patients in t...

Neurologic Manifestations Seen in Most Hospitalized With COVID-19

Oct 08, 2020

WEDNESDAY, Oct. 7, 2020 (HealthDay News) -- Neurologic manifestations are common in COVID-19, occurring in 82.3 percent of hospitalized patients, according to a study published online Oct. 5 in the An...

Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy

Oct 08, 2020

WEDNESDAY, Oct. 7, 2020 (HealthDay News) -- Eli Lilly and Co. is seeking U.S. approval for emergency use of an experimental antibody therapy for COVID-19. The request to the U.S. Food and Drug Admi...

Six States Set Records for COVID-19 Hospitalizations

Oct 08, 2020

WEDNESDAY, Oct. 7, 2020 (HealthDay News) -- Records for COVID-19 hospitalizations were set Tuesday in six states -- Arkansas, Montana, North Dakota, South Dakota, Wisconsin, and Wyoming. Another st...

White House Approves Tougher Rules for COVID-19 Vaccine Development

Oct 08, 2020

WEDNESDAY, Oct. 7, 2020 (HealthDay News) -- Following weeks of delay, the White House on Tuesday approved tough new rules for COVID-19 vaccine developers that will make it unlikely that a vaccine will...

Poll: Only Half of Americans Would Try to Get COVID-19 Vaccine

Oct 07, 2020

TUESDAY, Oct. 6, 2020 (HealthDay News) -- Only 51 percent of Americans would get a COVID-19 vaccine, while 45 percent would not even try, a new poll shows. About 4 percent of respondents had no opi...

ACP Backs Remdesivir Tx for Patients with Covid-19

Oct 07, 2020

Organization recommends 5-day treatment course over standard 10-day course for moderate disease PHILADELPHIA — The American College of Physicians released new Rapid Living Practice Points backing t...

Covid-19: Azithromycin Appears to Have No Benefit in Hospitalized Patients

Oct 07, 2020

No benefit in clinical progression seen in COALITION II study Adding azithromycin to hydroxychloroquine was not associated with better outcomes among patients hospitalized with severe Covid-19 in a l...

Covid-19: Lopinavir-Ritonavir Combo Falls Short—Again

Oct 07, 2020

RECOVERY trial findings don’t support use of lopinavir-ritonavir in hospitalized patients Lopinavir-ritonavir (Kaletra) failed to hasten recovery or reduce mortality for inpatients with Covid-19,...

Neuro-oncology Telephone Clinics during the COVID-19 Pandemic

Oct 07, 2020

The outbreak of coronavirus has affected millions of people worldwide. This has socially distanced the people to such an extent that the people are fearful of being near to each other/ this outbreak h...

COVID-19 Mortality Higher in Patients With Parkinson Disease

Oct 06, 2020

MONDAY, Oct. 5, 2020 (HealthDay News) -- COVID-19-related case fatality rates are higher for patients with Parkinson disease (PD), independent of age, sex, and race, according to a research letter pub...

CDC Now Acknowledges Airborne Transmission of COVID-19

Oct 06, 2020

MONDAY, Oct. 5, 2020 (HealthDay News) -- Infection with the new coronavirus can occur through airborne transmission between people farther than 6 feet apart, the U.S. Centers for Disease Control and P...

Daily COVID-19 Cases in U.S. Highest in Months

Oct 06, 2020

MONDAY, Oct. 5, 2020 (HealthDay News) -- The highest daily rate of new COVID-19 cases in the United States in nearly two months was reported late last week. There were 54,506 new reported cases on ...

SUBSPECIALTIES

Advertisement